Related Experiment Video
Updated: Jun 12, 2026

Homogeneous Glycoconjugate Produced by Combined Unnatural Amino Acid Incorporation and Click-Chemistry for Vaccine Purposes
Published on: December 19, 2020
Protective efficacy of group A streptococcal vaccines containing type-specific and conserved M protein epitopes
Thomas A Penfound1, Edna Y Chiang, Elwaleed A Ahmed
1Department of Medicine, University of Tennessee Health Science Center, Memphis, TN 38163, United States.
Abstract:
The amino terminal region of group A streptococcal M proteins evokes type-specific immunity while the conserved C-repeat epitopes evoke cross-protective immunity against multiple serotypes. The present studies were undertaken to compare the protective efficacy of vaccines containing either type-specific (hexavalent vaccine) or conserved C-repeat (J14 vaccine) M protein epitopes and to determine if combination vaccines resulted in enhanced levels of protection. Our results indicated that the protective efficacy of the type-specific vaccine was significantly greater than that of J14 and that the addition of J14 to vaccine formulations did not enhance the level of protection achieved with type-specific formulations.
Related Concept Videos
Streptococcal Pharyngitis
Cross-reactivity
Vaccines
Vaccinations
Antigens Involved in Adaptive Immunity
Complete Antigens
Complete antigens possess both immunogenicity and reactivity.
Smallpox

